Loading...
ROCO
4121
Market cap34mUSD
Oct 08, Last price  
13.25TWD
1D
3.52%
1Q
-0.38%
Jan 2017
11.72%
IPO
-33.25%
Name

Rossmax International Ltd

Chart & performance

D1W1MN
ROCO:4121 chart
P/E
—
P/S
0.29
EPS
—
Div yield, %
3.77%
Shrs. gr., 5y
2.33%
Rev. gr., 5y
0.65%
Revenues
3.80b
-1.34%
3,093,951,0003,678,969,0003,947,903,0004,344,948,0003,809,262,0003,851,358,0003,799,559,000
Net income
-30m
L+1.87%
25,727,000135,463,000111,374,000170,267,000-6,665,000-29,348,000-29,897,000
CFO
284m
-9.52%
0459,345,000575,427,000434,206,000302,354,000314,103,000284,199,000
Dividend
Jun 12, 20240.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Rossmax International Ltd. is dedicated to creating and delivering a wide array of healthcare products and solutions. Their diverse product lineup includes advanced diagnostic and monitoring devices such as body composition scales, which provide readings for body fat, BMI, lean mass, muscle mass, water ratio, and overall body weight. They also offer various blood pressure monitors, including traditional sphygmomanometers, stethoscopes for internal sound auscultation, portable pulse oximeters for tracking blood oxygen saturation, non-contact infrared thermometers, and blood glucose monitoring systems for diabetes management. The company further extends its offerings to therapeutic and assistive medical equipment. This includes nebulizers for mist-based medication delivery, suction units for removing bodily fluids, aero spacers to enhance aerosolized drug administration, peak flow meters for respiratory function assessment, therapeutic heating pads, and anti-decubitus mattresses. Complementing its hardware, Rossmax provides the Healthstyle app, a unified digital platform enabling users to conveniently track key health metrics like blood pressure, blood glucose, SpO2, weight, and temperature. Rossmax's solutions cater to a broad spectrum of medical fields, including cardiovascular health, diabetes, respiratory conditions, fever management, and wound care. They also offer a specialized range of thermometers, scales, and nebulizers specifically designed for pediatric use. Founded in 1988 and headquartered in Taipei, Taiwan, Rossmax International Ltd. operates with a strong global footprint. The company exports its products and maintains active operations in numerous international markets, spanning Taiwan, Italy, Brazil, Mainland China, Germany, Ukraine, Poland, Iraq, India, the United Kingdom, Japan, and Turkey.

Key people

Zhiping Liu
Chairman of the Board, General Manager · since 2017
Lily Chan
Finance Manager, Head of Finance & Accounting · since 2025
Lixian Chen
Deputy General Manager-Administration Management · since 2018
Zhirong Chen
Deputy General Manager-Deputy General Manager's Office · since 2011
Yuqiao Qi
Deputy General Manager-R&D and Quality Management Division · since 2011
Morten Brunvoll
Director · since 2011
Director · since 2023
Zonghan Li
Director · since 2020
Zhizhong Wu
Director · since 2020
Qingwei Zhang
Director · since 2023
Yixun Chen
Independent Director · since 2023
Yanping Ji
Independent Director · since 2023
Independent Director · since 2023
Xuanguang Zhou
Independent Director · since 2023
IPO date
Nov 28, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT